<p>Statistically significant differences between controls and bladder cancer patient sub-cohorts with data normalization to the sum of all endogenous hexoses or HexNAcs.</p
There are little data on the putative association between factors in the metabolic syndrome (MetS) a...
<p>Columns 1–3: liver neoplasms, bladder neoplasms, and bladder carcinomas, respectively; Rows 1–3: ...
<p>Hazard ratios are based on time to subsequent cancer compared to controls, adjusted for age at re...
<p>Statistically significant differences between controls and bladder cancer patient sub-cohorts<a h...
<p>Cohort 1 All Cnt (all controls) represents combined data for BCa negative: normal, history and he...
<p>The averaged chromatograms for the bladder cancer group and the control group shown on the same s...
<p>Patient distributions are shown in (a-d). The Kruskal-Wallis test was performed followed by Dunn’...
<p><b>A</b>. Frequency distribution of XPC IRS classifications in 47 TURB samples. <b>B</b>. Frequen...
Objective: In this study, we aimed to compare plasma endoglin and endocan levels between bladder can...
*<p>Compared with "female normal controls".</p>**<p>Compared with "total normal controls".</p><p>Fol...
<p>M1: homozygote comparison; M2: heterozygote comparison; M3: dominant model; M4: recessive model; ...
a<p>Student's t-test for age distribution between the cases and controls; two-sided χ<sup>2</sup> te...
Objectives To compare patient and tumour characteristics at presentation from two large bladder canc...
Objectives To compare patient and tumour characteristics at presentation from two large bladder canc...
Objectives To compare patient and tumour characteristics at presentation from two large bladder canc...
There are little data on the putative association between factors in the metabolic syndrome (MetS) a...
<p>Columns 1–3: liver neoplasms, bladder neoplasms, and bladder carcinomas, respectively; Rows 1–3: ...
<p>Hazard ratios are based on time to subsequent cancer compared to controls, adjusted for age at re...
<p>Statistically significant differences between controls and bladder cancer patient sub-cohorts<a h...
<p>Cohort 1 All Cnt (all controls) represents combined data for BCa negative: normal, history and he...
<p>The averaged chromatograms for the bladder cancer group and the control group shown on the same s...
<p>Patient distributions are shown in (a-d). The Kruskal-Wallis test was performed followed by Dunn’...
<p><b>A</b>. Frequency distribution of XPC IRS classifications in 47 TURB samples. <b>B</b>. Frequen...
Objective: In this study, we aimed to compare plasma endoglin and endocan levels between bladder can...
*<p>Compared with "female normal controls".</p>**<p>Compared with "total normal controls".</p><p>Fol...
<p>M1: homozygote comparison; M2: heterozygote comparison; M3: dominant model; M4: recessive model; ...
a<p>Student's t-test for age distribution between the cases and controls; two-sided χ<sup>2</sup> te...
Objectives To compare patient and tumour characteristics at presentation from two large bladder canc...
Objectives To compare patient and tumour characteristics at presentation from two large bladder canc...
Objectives To compare patient and tumour characteristics at presentation from two large bladder canc...
There are little data on the putative association between factors in the metabolic syndrome (MetS) a...
<p>Columns 1–3: liver neoplasms, bladder neoplasms, and bladder carcinomas, respectively; Rows 1–3: ...
<p>Hazard ratios are based on time to subsequent cancer compared to controls, adjusted for age at re...
DOI
Add to ORKG